NDC 50242-137
Actemra 400 mg per 20 mL injection, solution, concentrate
On the label: Genentech, Inc..
Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Genentech, Inc. | Oceanside, CA, United States | Makes the active ingredient and tests it | No problems foundAug 16, 2024 · 5 inspections |
| Genentech, Inc. | Hillsboro, OR, United States | Makes it, tests it, packages it and labels it | Problems found, fixed voluntarilyApr 19, 2024 · 7 inspections |
| F. Hoffmann-La Roche AG | Kaiseraugst, Switzerland | Tests it, packages it and labels it | Problems found, fixed voluntarilyMar 21, 2025 · 8 inspections |
| Roche Diagnostics GmbH | Mannheim, Germany | Tests it, packages it and labels it | Problems found, fixed voluntarilyOct 29, 2021 · 5 inspections |
| Roche Diagnostics GmbH | Penzberg, Germany | Tests it | Problems found, fixed voluntarilyMay 22, 2025 · 6 inspections |
Product details
- Generic drug
- Tocilizumab: every company that makes it
- Form
- injection, solution, concentrate, intravenous
- Strength
- 400 mg per 20 mL
- Approval
- BLA BLA125276
- On the market since
- Jan 8, 2010
- Package NDCs
50242-137-01- Official label
- DailyMed (National Library of Medicine), updated Dec 16, 2025
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?